Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?

Garvey, Lene H; Nasser, Shuaib

Garvey, Lene H; Nasser, Shuaib.

Garvey LH; Allergy Clinic, Department of Dermatology and Allergy, Copenhagen University Hospital, Gentofte, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: lene.heise.garvey@regionh.dk.
Nasser S; Department of Allergy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Br J Anaesth ; 126(3): e106-e108, 2021 03.

Article in English | MEDLINE | ID: covidwho-1002370

Subject(s)

Anaphylaxis/chemically induced; Anaphylaxis/diagnosis; COVID-19 Vaccines/administration & dosage; Polyethylene Glycols/adverse effects; COVID-19 Vaccines/adverse effects; Humans; Polyethylene Glycols/administration & dosage; Surface-Active Agents/administration & dosage; Surface-Active Agents/adverse effects

Keywords

COVID-19; allergy; anaphylaxis; drug allergy; hypersensitivity; polyethylene glycol; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polyethylene Glycols / COVID-19 Vaccines / Anaphylaxis Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Br J Anaesth Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google